Proteases in COPD: A critical pathway to injury

Chest

Volumn 132, Issue 6, 2007, Pages 1724-1725

  Turino, Gerard M ^a,b,c,d  

^a Columbia University College of Physicians and Surgeons ^*

^b St luke'S roosevelt Hospital ^*

^c St luke'S roosevelt Hospital

^d ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE 3; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; LEUKOCYTE ELASTASE; METALLOPROTEINASE; NEUTROPHIL COLLAGENASE;

CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE COURSE; EDITORIAL; ENZYME ACTIVITY; ENZYME MECHANISM; FORCED EXPIRATORY VOLUME; HUMAN; LUNG ALVEOLUS CELL TYPE 2; LUNG EMPHYSEMA; LUNG LAVAGE; LUNG PARENCHYMA; MACROPHAGE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOKING; SPUTUM ANALYSIS;

EID: 37549018951     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.07-1572     Document Type: Editorial

References (17)

1. Laurell C-B, Eriksson A. The electrophoretic α-1-globulin pattern of serum in α-1-antitrypsin deficiency. Scand J Clin Lab Invest 1963, 15:132-140
2. Janoff A. Elastases and emphysema: current assessment of the protease-antiprotease hypothesis. Am Rev Respir Dis 1985, 132:417-433
3. Stockley RA. Proteolytic enzymes: their inhibitors and lung disease. Clin Sci 1983, 64:119-126
4. Shapiro SD. Proteinases in chronic obstructive pulmonary disease. Biochem Soc Trans 2002, 30:98-102
5. Elkington PTF, Friedland JS. Matrix metalloproteinases in destructive pulmonary pathology. Thorax 2006, 61:259-266
6. Baraldo S, Bazzan E, Zanin ME, et al. Matrix metalloproteinase-2 protein in lung periphery is related to COPD progression. Chest 2007; 132:1733-1740
7. Imai K, Dalal SS, Chen ES, et al. Human collagenase (matrix metalloproteinase-1) expression in the lungs of patients with emphysema. Am J Respir Crit Care Med 2001, 163:786-791
8. Ohnishi K, Takagi M, Kurokawa Y, et al. Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema. Lab Invest 1998, 78:1077-1087
9. Vernooy JH, Lindeman JH, Jacobs JA, et al. Increased activity of matrix metalloproteinase-8 and matrix metalloproteinase-9 in induced sputum from patients with COPD. Chest 2004, 126:1082-1010
10. Finlay GA, Russell KJ, McMahon KJ, et al. Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysematous patients. Thorax 1997, 52:502-506
11. Culpitt S, Rogers D, Traves S, et al. Sputum matrix metalloproteases: comparison between chronic obstructive pulmonary disease and asthma. Respir Med 2005, 99:703-710
12. Shapiro SD. The macrophage in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999, 160:S29-S32
13. Finlay GA, O'Driscoll LR, Russell KJ, et al. Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. Am J Respir Crit Care Med 1997, 156:240-247
14. Russell REK, Russell SV, Culpitt CDM, et al. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2002, 26:602-609
15. Geraghty P, Rogan MP, Green CM, et al. Upregulation of cathepsin B and matrix metalloproteiase-2 by neutrophil elastase [abstract]. Am J Respir Crit Care Med 2007; 175:A740
16. Lee SH, Goswami S, Grudo A, et al. Antielastin autoimmunity in tobacco smoking-induced emphysema. Nature Med 2007, 13:567-569
17. Senior RM, Griffin GL, Mecham RP, et al. Val-Gly-Val-Ala-Pro-Gly: a repeating peptide in elastin is chemotactic for fibroblasts and monocytes. J Cell Biol 1984, 99:870-874